The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease
Abstract
Background The pathological hallmarks of Alzheimer's disease (AD) include accumulation of amyloid-β (Aß) peptide forming extracellular senile plaques, neurofibrillary tangles made of hyperphosphorylated tau protein with neuronal loss. Aβ peptide (1-42), total tau (T-tau), and phosphorylated tau at threonine 181 (p181tau) levels in the cerebrospinal fluid (CSF) are now validated biomarkers. The proapoptotic kinase R (PKR), is activated by Aβ accumulates in degenerating neurons in AD brains and controls protein synthesis and indirectly tau phosphorylation. Methods In a prospective cohort study, the CSF of 91 patients were studied (AD: 45; amnestic mild cognitive impairment: 11; neurological disease control subjects [NDC]: 35). The levels of total PKR (T-PKR), phosphorylated PKR (pPKR), Aß 1-42, T-tau, and p181tau were assessed by immunoblotting or enzyme-linked immunosorbent assay methods. Receivers operating characteristic curves were used to examine the discriminatory power of T-PKR, pPKR, and pPKR/T-PKR ratio between AD and NDC patients. Results Total PKR and pPKR concentrations were elevated in AD and amnestic mild cognitive impairment subjects. We have determined a pPKR value (optical density units) that could discriminate AD patients from control subjects with a sensitivity of 91.1% and a specificity of 94.3%. Among AD patients, T-PKR and pPKR levels correlate with CSF p181tau levels. Some AD patients with normal CSF Aß, T-tau, or p181tau levels had abnormal T-PKR and pPK…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings are consistent with previous reports that cellular detectors of dsRNA such as protein kinase RNA-activated (PKR) are elevated in brains of patients with Alzheimer’s disease (42–45).”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [43]
Citations
Cites
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Tapiola, T., Alafuzoff, I., Herukka, S.-K., Parkkinen, L., Hartikainen, P., Soininen, H., & Pirttilä, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.596 · Cited by 896
PKR; a sentinel kinase for cellular stress
Williams, B. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203127 · Cited by 820
The dsRNA protein kinase PKR: Virus and cell control
García, M. A., Meurs, E. F., & Esteban, M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.001 · Cited by 644
Relationships between biomarkers in aging and dementia
Jagust, W. J., Landau, S. M., Shaw, L. M., Trojanowski, J. Q., Koeppe, R. A., Reiman, E. M., Foster, N. L., Petersen, R. C., Weiner, M. W., Price, J. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc010c · Cited by 456
Chang, R. C. C., Wong, A. K. Y., Ng, H.-K., & Hugon, J. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00011 · Cited by 289
Self-citationGrimmer, T., Riemenschneider, M., Förstl, H., Henriksen, G., Klunk, W. E., Mathis, C. A., Shiga, T., Wester, H.-J., Kurz, A., & Drzezga, A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.027 · Cited by 278
Chang, R. C., Suen, K., Ma, C., Elyaman, W., Ng, H., & Hugon, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01237.x · Cited by 180
Self-citationPeel, A. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00086-x · Cited by 125
Research works printed but not linked: 27
- Rossor, 2010, The diagnosis of young-onset dementia, Lancet Neurol, 9, 793, 10.1016/S1474-4422(10)70159-9 · DOI · Paper page
- Duyckaerts, 2009, Classification and basic pathology of Alzheimer disease, Acta Neuropathol, 118, 5, 10.1007/s00401-009-0532-1 · DOI · Paper page
- Petersen, 2001, Current concepts in mild cognitive impairment, Arch Neurol, 58, 1985, 10.1001/archneur.58.12.1985 · DOI · Paper page
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Steele, 2011, Apomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation?, Ann Neurol, 69, 221, 10.1002/ana.22359 · DOI
- Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria, Lancet Neurol, 6, 734, 10.1016/S1474-4422(07)70178-3 · DOI · Paper page
- McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
- Dumurgier, 2010, Inverse association between CSF Abeta 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory, Neurobiol Dis, 40, 456, 10.1016/j.nbd.2010.07.007 · DOI
- Hotamisligil, 2010, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease, Cell, 140, 900, 10.1016/j.cell.2010.02.034 · DOI · Paper page
- Nakamura, 2010, Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis, Cell, 140, 338, 10.1016/j.cell.2010.01.001 · DOI · Paper page
- Paquet, 2011, The PKR activator PACT is induced by Aβ: Involvement in Alzheimer's disease, Brain Pathol
- Page, 2006, Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease, Neuroscience, 139, 1343, 10.1016/j.neuroscience.2006.01.047 · DOI · Paper page
- Onuki, 2004, An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease, EMBO J, 23, 959, 10.1038/sj.emboj.7600049 · DOI · Paper page
- Bose, 2011, Modulation of tau phosphorylation by the kinase PKR: Implications in Alzheimer's disease, Brain Pathol, 21, 189, 10.1111/j.1750-3639.2010.00437.x · DOI
- Ill-Raga, 2011, Activation of PKR causes amyloid ss-peptide accumulation via de-repression of BACE1 expression, PLoS One, 6, e21456, 10.1371/journal.pone.0021456 · DOI
- McKhann, 1984, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- Paquet, 2009, Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease, J Neuropathol Exp Neurol, 68, 190, 10.1097/NEN.0b013e318196cd7c · DOI
- DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 · DOI · Paper page
- Yeung, 1996, An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells, Proc Natl Acad Sci U S A, 93, 12451, 10.1073/pnas.93.22.12451 · DOI · Paper page
- Ballard, 2011, Alzheimer's disease, Lancet, 377, 1019, 10.1016/S0140-6736(10)61349-9 · DOI · Paper page
- Querfurth, 2010, Alzheimer's disease, N Engl J Med, 362, 329, 10.1056/NEJMra0909142 · DOI · Paper page
- Zotova, 2010, Inflammation in Alzheimer's disease: Relevance to pathogenesis and therapy, Alzheimers Res Ther, 2, 1, 10.1186/alzrt24 · DOI · Paper page
- Kim, 2010, Activation of eukaryotic initiation factor-2 alpha-kinases in okadaic acid-treated neurons, Neuroscience, 169, 1831, 10.1016/j.neuroscience.2010.06.016 · DOI
- Bando, 2005, Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease, Neurochem Int, 46, 11, 10.1016/j.neuint.2004.07.005 · DOI · Paper page
- Peel, 2001, Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue, Hum Mol Genet, 10, 1531, 10.1093/hmg/10.15.1531 · DOI · Paper page
- Paccalin, 2006, Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease, Dement Geriatr Cogn Disord, 22, 320, 10.1159/000095562 · DOI · Paper page
- Hugon, 2009, Could PKR inhibition modulate human neurodegeneration?, Expert Rev Neurother, 9, 1455, 10.1586/ern.09.92 · DOI
Cited by
The integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 495
Gal-Ben-Ari, S., Barrera, I., Ehrlich, M., & Rosenblum, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00480 · Cited by 254
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Hansson, O., Zetterberg, H., Bouaziz-Amar, E., Hugon, J., Paquet, C., & Blennow, K. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0208-8 · Cited by 184
Self-citationBiomarkers in Sporadic and Familial Alzheimer’s Disease
Lista, S., O’Bryant, S. E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., & Hampel, H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143006 · Cited by 106
Self-citation
Metadata
- Authors
- Mouton-Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J.-L., & Hugon, J.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 71
- Issue
- 9
- Pages
- 829-835
- ISSN
- 0006-3223
- Cited by
- 60
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease. https://app.cochat.ai/papers/10.1016/j.biopsych.2011.11.031
- The paper
- Mouton-Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J.-L., & Hugon, J. (2012). Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2011.11.031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.